The market is expanding at a CAGR of 5.35% between 2026 and 2035
Larsen said that Novo expects a "very strong uptake" of the Wegovy pill internationally but not necessarily with the same kind of curve as in the U.S
By the numbers, more than 40% of adults in the United States have obesity, to say nothing of the millions more who are overweight
Zepbound is contraindicated for those with personal or family histories of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal disease, or pancreatitis histories
However, only two samples were tested, which cannot verify the quality of all products sold
Patients should not discontinue semaglutide due to UTI concerns without consulting their prescribing physician, as the metabolic benefits typically outweigh any theoretical indirect risks